Sitemap
Pages
Posts
- In Vitro ADME Studies: Laying the Foundation for Preclinical Success
- A Complete Preclinical CRO Checklist: What Companies Need Before Outsourcing Toxicology & Bioanalysis
- Achieving The FDA Requirements Related To Going From Method Development Through Validation, And Doing It Cost Effectively
- Bioanalytical Method Development: Best Practices for Regulatory Compliant Data
- Biotech Innovator InfinixBio Welcomes Jennifer Logan as New Chief Marketing Officer to Drive Business Development and Strategic Growth
- Celebrating a New Milestone in Alzheimer’s Research
- Defining the Process of Assay Development and Validation
- First-in-Human Dosing: CRO Support for a Seamless Phase 1 Transition
- From Concept to Reality: The Journey of Assay Development and Validation with InfinixBio
- From Hit-to-Lead: How CRO Partnerships Accelerate Drug Discovery Timelines
- How a leading biotechnology company partnered with InfinixBio to engineer and deliver usable strains for their line of custom therapeutic antibodies.
- How Bacteria Develop Resistance to Drugs?
- How Is Gene Therapy Being Used for Disease Treatment?
- How to Design Biomarker-Driven Clinical Trials for Better Outcomes & Lower Risk
- How to Ensure Data Integrity in Preclinical Studies: A Guide for Sponsors
- How To Establish Bio Analysis And Animal Studies And Bridge Them To The Clinical Study
- How To Meet The Regulatory Requirements For Preclinical Assay Development
- InfinixBio & NCH Partner on TSC Therapeutic
- InfinixBio Announces New Pharmacokinetics Division
- InfinixBio Appoints Craig McElroy, Ph.D., as Vice President of Pharmacokinetics Division
- InfinixBio To Present Breakthrough Anticancer Technology at The AACR Annual Meeting, Sunday, April 16, 2023, In Orlando, Florida
- Innovations in Genetic Engineering: New Tools, Gene Editing, and Synthetic Biology in Bioproduction
- Phase 1 vs. Phase 2 Trials: CRO Support Across Clinical Milestones
- Small Molecule Optimization in the Preclinical Phase: Accelerating the Path to Clinical Success
- Structure and Function of a Dual Antagonist of the Human Growth Hormone and Prolactin Receptors with Site-specific PEG Conjugates: A Revolutionary Development
- Supporting Threat Agent Science: The CRO Advantage in Medical Countermeasure (MCM) Development
- Target Identification vs. Target Validation: What’s the Difference in Early Drug Discovery?
- The Future of Gene Therapy Immunogenicity Assessment
- The Role of InfinixBio in Accelerating Pre-Clinical Research
- Unlocking Innovation: Custom Genetic Engineering Services for Biotech Companies
- What Are IND-Enabling Studies and Why Are They Critical to Drug Development?
- What Are the Challenges in Analyzing Biospecific Anti-Drug Antibodies?
- What Are the Stages of Drug Development?
- What Is CMC In Drug Development
- Why Are Patents Important to Drug Development?
- Why The Company Conducting Your Animal Studies Is Not The Best Choice To Do The Assay Development Through Assay Validation
